BRPI1014878A2 - "produção de nanopartículas encapsuladas em frações de alto volume." - Google Patents

"produção de nanopartículas encapsuladas em frações de alto volume."

Info

Publication number
BRPI1014878A2
BRPI1014878A2 BRPI1014878A BRPI1014878A BRPI1014878A2 BR PI1014878 A2 BRPI1014878 A2 BR PI1014878A2 BR PI1014878 A BRPI1014878 A BR PI1014878A BR PI1014878 A BRPI1014878 A BR PI1014878A BR PI1014878 A2 BRPI1014878 A2 BR PI1014878A2
Authority
BR
Brazil
Prior art keywords
production
high volume
volume fractions
encapsulated nanoparticles
nanoparticles
Prior art date
Application number
BRPI1014878A
Other languages
English (en)
Inventor
Aaron Dodd
Adrian Russell
Felix Meiser
Marck Norret
William H Bosch
Original Assignee
Iceutica Pty Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from AU2009901744A external-priority patent/AU2009901744A0/en
Application filed by Iceutica Pty Ltd filed Critical Iceutica Pty Ltd
Publication of BRPI1014878A2 publication Critical patent/BRPI1014878A2/pt

Links

Classifications

    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J2/00—Processes or devices for granulating materials, e.g. fertilisers in general; Rendering particulate materials free flowing in general, e.g. making them hydrophobic
    • B01J2/18—Processes or devices for granulating materials, e.g. fertilisers in general; Rendering particulate materials free flowing in general, e.g. making them hydrophobic using a vibrating apparatus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/145—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/146—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B02—CRUSHING, PULVERISING, OR DISINTEGRATING; PREPARATORY TREATMENT OF GRAIN FOR MILLING
    • B02C—CRUSHING, PULVERISING, OR DISINTEGRATING IN GENERAL; MILLING GRAIN
    • B02C17/00—Disintegrating by tumbling mills, i.e. mills having a container charged with the material to be disintegrated with or without special disintegrating members such as pebbles or balls
    • B02C17/14—Mills in which the charge to be ground is turned over by movements of the container other than by rotating, e.g. by swinging, vibrating, tilting
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B02—CRUSHING, PULVERISING, OR DISINTEGRATING; PREPARATORY TREATMENT OF GRAIN FOR MILLING
    • B02C—CRUSHING, PULVERISING, OR DISINTEGRATING IN GENERAL; MILLING GRAIN
    • B02C17/00—Disintegrating by tumbling mills, i.e. mills having a container charged with the material to be disintegrated with or without special disintegrating members such as pebbles or balls
    • B02C17/18—Details
    • B02C17/20—Disintegrating members

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Food Science & Technology (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Preparation (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Manufacturing Of Micro-Capsules (AREA)
BRPI1014878A 2009-04-24 2010-04-23 "produção de nanopartículas encapsuladas em frações de alto volume." BRPI1014878A2 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US17227809P 2009-04-24 2009-04-24
AU2009901744A AU2009901744A0 (en) 2009-04-24 Production of Encapsulated Nanoparticles at High Volume Fractions
PCT/AU2010/000464 WO2010121320A1 (en) 2009-04-24 2010-04-23 Production of encapsulated nanoparticles at high volume fractions

Publications (1)

Publication Number Publication Date
BRPI1014878A2 true BRPI1014878A2 (pt) 2016-05-03

Family

ID=43010603

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI1014878A BRPI1014878A2 (pt) 2009-04-24 2010-04-23 "produção de nanopartículas encapsuladas em frações de alto volume."

Country Status (21)

Country Link
US (6) US20120165410A1 (pt)
EP (2) EP2421509B1 (pt)
JP (2) JP6141012B2 (pt)
KR (3) KR101848766B1 (pt)
CN (2) CN102438593A (pt)
AP (1) AP3138A (pt)
AU (1) AU2010239159C1 (pt)
BR (1) BRPI1014878A2 (pt)
CA (1) CA2759102A1 (pt)
CO (1) CO6470805A2 (pt)
DK (1) DK2421509T3 (pt)
EA (1) EA201171279A1 (pt)
IL (2) IL254370B2 (pt)
MA (1) MA33297B1 (pt)
MX (1) MX356518B (pt)
MY (1) MY159098A (pt)
NZ (1) NZ595973A (pt)
SG (1) SG175309A1 (pt)
UA (1) UA110322C2 (pt)
WO (1) WO2010121320A1 (pt)
ZA (1) ZA201108651B (pt)

Families Citing this family (40)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK2054042T3 (da) 2006-06-30 2020-08-03 Iceutica Pty Ltd Fremgangsmåder til fremstilling af biologisk aktive forbindelser i nanopartikelform
CA2759109A1 (en) * 2009-04-24 2010-10-28 Iceutica Pty Ltd A solid dosage form of ciprofloxacin having small particle size and improved powder handling characteristics
BRPI1014275B8 (pt) 2009-04-24 2021-05-25 Iceutica Pty Ltd composição que compreende partículas de indometacina dispersas em pelo menos dois materiais de moagem parcialmente moídos
AU2010239082B2 (en) * 2009-04-24 2014-10-16 Iceutica Pty Ltd A novel formulation of metaxalone
WO2010121326A1 (en) * 2009-04-24 2010-10-28 Iceutica Pty Ltd A novel formulation of naproxen
SG10201401705VA (en) * 2009-04-24 2014-08-28 Iceutica Pty Ltd Production of encapsulated nanoparticles at commercial scale
US20110009347A1 (en) 2009-07-08 2011-01-13 Yin Liang Combination therapy for the treatment of diabetes
ES2596291T3 (es) * 2010-05-11 2017-01-05 Janssen Pharmaceutica, N.V. Formulaciones farmacéuticas que comprenden derivados de 1-(beta-d-glucopiranosil)-2-tienilmetilbenceno como inhibidores de sglt
CN103596944B (zh) 2011-04-13 2017-02-22 詹森药业有限公司 可用作sglt2的抑制剂的化合物的制备方法
EP2712628B1 (en) 2012-09-28 2016-08-10 Shanta Banerjee Composition for use as a medicine or dietetic food, in particular in the prevention and/or treatment of Diabetes and diabetes associated diseases
BR112015020572B1 (pt) * 2013-02-28 2022-02-22 Sun Chemical Corporation Processo contínuo para transformar sólido moído em dispersão líquida e aparelho
DK3024440T3 (en) * 2013-07-22 2019-03-11 Iceutica Inc METAXALON FORMULATION
US20150157646A1 (en) 2013-09-27 2015-06-11 Iceutica Inc. Abiraterone Steroid Formulation
ES2542088B1 (es) * 2014-01-29 2016-05-05 Enoc Solutions, S.L. Composición de azufre liposomado
US9526734B2 (en) 2014-06-09 2016-12-27 Iceutica Pty Ltd. Formulation of meloxicam
CN104174468B (zh) * 2014-08-27 2016-06-15 上海延安药业有限公司 粘稠性药物锆珠研磨方法
EP3307677A1 (en) * 2015-05-20 2018-04-18 Université Pierre et Marie Curie (Paris 6) Mechanochemical process for the production of BP, B12P2 and mixtures thereof, in particular as nanopowders
EP3331495B1 (en) 2015-08-03 2020-11-04 Tolmar International Limited Liquid polymer delivery system for extended administration of drugs
US9732303B2 (en) 2016-01-06 2017-08-15 The Procter & Gamble Company Microcapsules formed from phosphate esters and compositions containing same
US10154947B2 (en) 2016-01-06 2018-12-18 The Procter & Gamble Company Antiperspirant composition
US9730867B2 (en) 2016-01-06 2017-08-15 The Procter & Gamble Company Methods of forming a slurry with microcapsules formed from phosphate esters
US9975255B1 (en) * 2016-12-15 2018-05-22 Jabil Inc. Apparatus, system and method for providing a conformable vacuum cup for an end effector
CN107417640B (zh) * 2017-02-22 2019-03-26 浙江大学 纳米噻唑锌的制备方法
CN107198677B (zh) * 2017-05-25 2021-07-09 长春金赛药业有限责任公司 黄体酮混悬型长效注射剂及其制备方法和黄体酮混悬注射粉针
KR102105872B1 (ko) * 2018-05-18 2020-04-29 강원대학교산학협력단 열용융압출법을 이용하여 제조된 구리 나노콜로이드 분산체 및 이의 용도
WO2019238261A1 (en) 2018-06-15 2019-12-19 Ramirez Rios Liliana Patricia METAL COMPLEXES OF β-DIKETONES AND/OR POLYPHENOLS BY GREEN CHEMISTRY, PREPARATION METHOD THEREOF, SUNSCREEN THEREOF, SKIN OR HAIR TONE CONCEALER THEREOF, HAIR DYEING THEREOF AND OTHER USES THEREOF
CN108902480A (zh) * 2018-07-27 2018-11-30 河南大华生物技术有限公司 一种提高饲料中微量添加物均匀度和生物利用度的方法
CN108904506A (zh) * 2018-07-27 2018-11-30 河南大华生物技术有限公司 一种地克珠利纳米粉末及其制备方法
TW202027725A (zh) * 2018-09-25 2020-08-01 愛爾蘭商托爾瑪國際有限公司 供藥物之延長投予之液體聚合物輸送系統
KR102359021B1 (ko) * 2019-07-29 2022-02-07 (주)케나프 가용성 플라보노이드 및 폴리페놀의 함량을 증진시키는 케나프 종자의 가공방법 및 이의 가공물
CN113133970A (zh) * 2020-01-17 2021-07-20 美国琛蓝营养制品股份有限公司 一种姜黄素复合物及其制备方法和检测方法
CN112674302A (zh) * 2021-01-07 2021-04-20 贵州山珍宝绿色科技开发有限公司 一种百香果刺梨果糕的制备方法
MX2023010120A (es) * 2021-03-03 2023-10-30 Pulmatrix Operating Co Inc Formulaciones de polvo seco de dihidroergotamina y metodos de uso.
CN113729011A (zh) * 2021-07-30 2021-12-03 安徽瑞然生物药肥科技有限公司 草甘膦可溶粒剂及其生产方法
JP2024178477A (ja) * 2021-11-04 2024-12-25 興和株式会社 カプセル剤
JP2024178478A (ja) * 2021-11-04 2024-12-25 興和株式会社 医薬品
AU2022388986A1 (en) * 2021-11-16 2024-06-13 Beijing Tide Pharmaceutical Co., Ltd. Nanocrystalline preparation of rock2 inhibitor and preparation method therefor
CN114210995B (zh) * 2021-12-17 2023-03-10 浙江大学 一种利用牛蒡根提取液制备纳米银颗粒的方法、产品和应用
EP4209212A1 (en) * 2022-01-05 2023-07-12 HWI pharma services GmbH Aqueous composition comprising avermectins
CN114671704B (zh) * 2022-04-22 2023-04-18 广州粤瓷新材料有限公司 一种低膨胀多孔堇青石及其制备方法

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU660852B2 (en) * 1992-11-25 1995-07-06 Elan Pharma International Limited Method of grinding pharmaceutical substances
US5478705A (en) 1994-05-25 1995-12-26 Eastman Kodak Company Milling a compound useful in imaging elements using polymeric milling media
US5500331A (en) 1994-05-25 1996-03-19 Eastman Kodak Company Comminution with small particle milling media
JP4117811B2 (ja) * 1997-04-22 2008-07-16 日本化薬株式会社 フルタミド製剤及びその製法
SA99191255B1 (ar) * 1998-11-30 2006-11-25 جي دي سيرل اند كو مركبات سيليكوكسيب celecoxib
AU5967101A (en) * 2000-05-10 2001-11-20 Rtp Pharma Inc Media milling
AU8847101A (en) 2000-08-31 2002-03-13 Rtp Pharma Inc Milled particles
ES2587135T3 (es) * 2000-11-30 2016-10-20 Vectura Limited Procedimiento de fabricación de partículas para su uso en una composición farmacéutica
JP2004099442A (ja) * 2002-09-04 2004-04-02 Nisshin Pharma Inc 難溶性薬物含有製剤およびその製造方法
KR20060024927A (ko) * 2004-09-15 2006-03-20 씨제이 주식회사 기계적 분쇄법에 의한 미크론 사이즈 인삼 분말의제조방법
CA2593862C (en) * 2004-12-31 2014-10-21 Iceutica Pty Ltd Nanoparticle composition and methods for synthesis thereof
CN101151428B (zh) 2005-02-08 2013-03-27 蒙基巴库普尔斯有限公司 加强筋
EP1973523A2 (en) * 2005-12-15 2008-10-01 Acusphere, Inc. Processes for making particle-based pharmaceutical formulations for pulmonary or nasal administration
JP2007169226A (ja) 2005-12-22 2007-07-05 Ono Pharmaceut Co Ltd 固体分散体
US8420122B2 (en) * 2006-04-28 2013-04-16 Merck Sharp & Dohme Corp. Process for the precipitation and isolation of 6,6-dimethyl-3-aza-bicyclo [3.1.0] hexane-amide compounds by controlled precipitation and pharmaceutical formulations containing same
CN102895194B (zh) * 2006-06-30 2015-09-09 伊休蒂卡有限公司 用于制备纳米粒形式的生物活性化合物的方法
DK2054042T3 (da) 2006-06-30 2020-08-03 Iceutica Pty Ltd Fremgangsmåder til fremstilling af biologisk aktive forbindelser i nanopartikelform
AR065802A1 (es) * 2007-03-22 2009-07-01 Schering Corp Formulaciones de comprimidos que contienen sales de 8- [( 1- ( 3,5- bis- (trifluorometil) fenil) -etoxi ) - metil) -8- fenil -1, 7- diaza- spiro [ 4,5] decan -2- ona y comprimidos elaborados a partir de estas
US8568696B2 (en) * 2008-08-06 2013-10-29 Indiana Nanotech Llc Grinding method for the manipulation or preservation of calcium phosphate hybrid properties
SG10201401705VA (en) * 2009-04-24 2014-08-28 Iceutica Pty Ltd Production of encapsulated nanoparticles at commercial scale
MA33293B1 (fr) * 2009-04-24 2012-05-02 Iceutica Pty Ltd Procédé d'amélioration du profil de dissolution d'une matière biologiquement active

Also Published As

Publication number Publication date
KR20150032759A (ko) 2015-03-27
JP6141012B2 (ja) 2017-06-07
JP6534689B2 (ja) 2019-06-26
US20240390871A1 (en) 2024-11-28
KR20120030384A (ko) 2012-03-28
CO6470805A2 (es) 2012-06-29
CN102438593A (zh) 2012-05-02
JP2017101045A (ja) 2017-06-08
NZ595973A (en) 2014-02-28
IL254370B2 (en) 2023-12-01
KR101743896B1 (ko) 2017-06-05
IL215867A0 (en) 2012-01-31
SG175309A1 (en) 2011-11-28
AP3138A (en) 2015-02-28
EP3338766A1 (en) 2018-06-27
CA2759102A1 (en) 2010-10-28
US20150306556A1 (en) 2015-10-29
MY159098A (en) 2016-12-15
DK2421509T3 (en) 2018-02-26
JP2012524716A (ja) 2012-10-18
US20200316546A1 (en) 2020-10-08
EA201171279A1 (ru) 2012-05-30
KR101848766B1 (ko) 2018-05-28
AU2010239159C1 (en) 2014-10-16
US20180243707A1 (en) 2018-08-30
EP2421509A4 (en) 2013-01-09
IL254370A0 (en) 2017-11-30
WO2010121320A1 (en) 2010-10-28
AU2010239159A1 (en) 2011-11-10
US20120165410A1 (en) 2012-06-28
US20170320030A1 (en) 2017-11-09
CN105663045A (zh) 2016-06-15
AP2011005993A0 (en) 2011-12-31
UA110322C2 (uk) 2015-12-25
EP2421509A1 (en) 2012-02-29
MX2011011230A (es) 2012-02-08
MA33297B1 (fr) 2012-05-02
IL254370B1 (en) 2023-08-01
ZA201108651B (en) 2013-01-30
MX356518B (es) 2018-05-31
AU2010239159B2 (en) 2014-06-12
EP2421509B1 (en) 2017-11-22
KR20160138326A (ko) 2016-12-02

Similar Documents

Publication Publication Date Title
BRPI1014878A2 (pt) "produção de nanopartículas encapsuladas em frações de alto volume."
IL214411A0 (en) Encapsulated nanoparticles
EP2487146A4 (en) hONEYCOMB STRUCTURE
PL3395876T3 (pl) Nowe nanocząstki
GB0903325D0 (en) Antibody molecules
EP2306992A4 (en) RELEASE PARTICLE
AP2011005996A0 (en) Production of encapsulated nanoparticles at commercial scale.
IL218763A0 (en) Anti-gcc antibody molecules and related compositions and methods
BRPI1014027A2 (pt) suspensão de fármaco de nanopartícula estável.
EP2419732A4 (en) PRION-FREE NANOPARTICLE COMPOSITIONS AND METHODS
PL2448734T3 (pl) Preforma, pojemnik i sposób formowania pojemnika
EP2333809A4 (en) Electron microscope
EP2646818A4 (en) SILICANANOPARTIKELKONJUGATE
PL3178494T3 (pl) Nanocząstki metaliczne, ich wytwarzanie i zastosowania
EP2511937A4 (en) ELECTRON MICROSCOPE
FR2929464B1 (fr) Nano resonnateur magnetique
EP2512452A4 (en) Antithrombotic nanoparticle
BRPI0911318A2 (pt) processo de produção de minério sinterizado
EP2555222A4 (en) ELECTRON MICROSCOPE
EP2573793A4 (en) ELECTRON MICROSCOPE
EP2481088A4 (en) PASSIVATED NANOPARTICLES
GB0811170D0 (en) Nanoparticles
GB0823119D0 (en) Super highway
BRPI0922256A2 (pt) composições de nanopartículas
IL220385A (en) Magnetite in nanoparticulate form

Legal Events

Date Code Title Description
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]

Free format text: NOTIFICACAO DE ANUENCIA RELACIONADA COM O ART 229 DA LPI

B06T Formal requirements before examination [chapter 6.20 patent gazette]
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]

Free format text: MANTIDO O INDEFERIMENTO UMA VEZ QUE NAO FOI APRESENTADO RECURSO DENTRO DO PRAZO LEGAL